2024 has been a year of exciting advancements at Aspen Biosciences, marked by the expansion of our Pipeline and PharmExchange platforms and the launch of innovative features designed to empower drug discovery efforts and to improve their capital efficiency. We’re thrilled to share some of the highlights: New Modules: New Features: Overall, these new modules […]
2024: Year In Review Read More »
This year saw a return to major industry events. Highlights included attending BioPharma PM, BioIT World, and BIO conferences and showcasing our Pipeline Program Management software. We launched a successful “Roadmap Informatics & Laboratory Planning Service” and completed significant client projects, including Diagnostics LIMS System, DEL Library Design & Screening, and Automated Synthesis modules.
Year in Review | Aspen Biosciences Read More »
Throughout this unprecedented year, Aspen Biosciences supported the biotech/pharma industry by providing safe return-to-work strategies and unbiased technology solutions. We assisted companies in selecting and optimizing ELN and LIMS systems, ensuring custom, efficient solutions through a collaborative, agile development process tailored to their specific needs.
Aspen Biosciences: Supporting Biotechnology and Pharmaceuticals in 2020 Read More »
As the country reopens, biotech companies navigate the new normal. They seek solutions for essential on-site personnel, productivity, and safe collaboration. Common strategies include hybrid work models, improved lab protocols, and increased use of virtual tools. Continuous evaluation ensures safety and efficiency.
Biotech Companies Adapting to COVID-19 Challenges: Strategies and Solutions Read More »
Pharm2Market 1.0, released in December 2018, expanded in 2019 with growing users and databases like San Francisco’s. The upcoming Pharm2Market 2.0, set for Q1 2020, brings enhanced features like iPhone support, autocuration, and richer queries for improved performance and usability.
Pharm2Market 2.0: Enhanced Performance and Access Pass Subscription | Q1 2020 Release Read More »
Partnering events like BIO, JP Morgan, the CLSA Pharma Partnering Day, and many others are critical opportunities for getting your message out to potential partners and investors. Learn how Pharm2Market can help.
Preparing for Partnering Events Read More »
Things have been pretty busy this month at Pharm2Market as we continue to grow our business intelligence service in the communities we serve.
Pharm2Market April Newsletter Read More »
In December, we launched Pharm2Market, a new business intelligence platform for biotech communities. The San Diego database has profiles for over 250 local drug discovery companies, over a dozen local investors, and 110 resource companies that provide everything from reagents to real estate services. In this presentation, we take a look behind those numbers to
San Diego By The Numbers Read More »
We take a look at the San Francisco drug discovery community and the stats behind the business development, investment, and partnering opportunities.
San Francisco By The Numbers Read More »
The new year has begun, and with it the search for new customers. We spoke with local biotech business development professionals to learn more about the detective-work they do to find new customers. Here’s what we learned.
Pharm2Market – Watching The Detectives Read More »
